Effect of Vitamin C in Autologous Stem Cell Transplantations
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
In the study the investigators will randomize patients that receive an autologous stem cell
transplantation for myeloma or lymphoma for treatment with vitamin C or placebo during 6
weeks. Primary endpoint will be immune recovery.